Pfm Health Sciences, LP has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $2.03 Billion distributed in 87 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $232M, Cytokinetics Inc with a value of $123M, Merck & Co., Inc. with a value of $78.7M, Abb Vie Inc. with a value of $73.5M, and Edwards Lifesciences Corp with a value of $70.7M.

Examining the 13F form we can see an increase of $436M in the current position value, from $1.59B to 2.03B.

Pfm Health Sciences, LP is based out at San Francisco, CA

Below you can find more details about Pfm Health Sciences, LP portfolio as well as his latest detailed transactions.

Portfolio value $2.03 Billion
Healthcare: $1.86 Billion
ETFs: $129 Million
Basic Materials: $34.3 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 87
  • Current Value $2.03 Billion
  • Prior Value $1.59 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 14, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 24 stocks
  • Additional Purchases 17 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 16 stocks
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.